MU:NASDAQMicron Technology, Inc. Analysis
Data as of 2026-05-22 - not real-time
$762.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Micron’s stock is trading well above its 20‑day and 50‑day simple moving averages, while remaining comfortably under the 200‑day average, signaling sustained bullish momentum.
The RSI sits in the upper‑mid range, supporting continued buying pressure, and the MACD line sits below its signal, hinting at a potential short‑term correction despite the broader bullish trend.
Fundamentally, the company posts robust revenue growth, high gross and operating margins, and strong cash conversion, while the dividend payout is modest but well‑covered by free cash flow, reinforcing dividend sustainability.
The RSI sits in the upper‑mid range, supporting continued buying pressure, and the MACD line sits below its signal, hinting at a potential short‑term correction despite the broader bullish trend.
Fundamentally, the company posts robust revenue growth, high gross and operating margins, and strong cash conversion, while the dividend payout is modest but well‑covered by free cash flow, reinforcing dividend sustainability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- MACD bearish histogram suggests a near‑term pullback risk
- Elevated RSI indicates strong buying pressure but also potential overbought condition
- Current price proximity to identified resistance level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- AI‑driven memory demand creating a structural growth tailwind
- Strong revenue growth and high operating margins relative to peers
- Robust cash flow generation and low relative debt burden
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Management’s narrative of a lasting AI memory cycle positioning Micron as a strategic asset
- Potential to scale toward a trillion‑dollar market valuation as AI adoption accelerates
- Long‑run expansion opportunities across data‑center, automotive, and embedded segments
Key Metrics & Analysis
Financial Health
Revenue Growth196.30%
Profit Margin41.49%
P/E Ratio34.6
ROE39.82%
ROA20.14%
Debt/Equity14.90
P/B Ratio11.9
Op. Cash Flow$30.7B
Free Cash Flow$2.9B
Industry P/E39.1
Technical Analysis
TrendBullish
RSI66.9
Support$488.23
Resistance$818.67
MA 20$656.03
MA 50$512.10
MA 200$319.34
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5
Valuation
Fair Value$94.62
Target Price$613.23
Upside/Downside-19.53%
GradeUndervalued
TypeGrowth
Dividend Yield0.08%
Risk Assessment
Beta2.64
Volatility78.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.